Zwitterionic Chitosan Derivatives for Nanoparticle Endotoxin Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Chitosan derivatives face challenges in parenteral administration due to immune activation, limited solubility, and non-specific toxicity, while PAMAM dendrimers have issues with systemic application and target cell interference, necessitating safer and more effective delivery methods.
Innovation Solution
Development of a zwitterionic chitosan derivative with a tunable pH-dependent charge profile, compatible with blood components, and a nanoparticle structure comprising this derivative and a dendrimer for pH-responsive delivery, reducing immune activation and enhancing target specificity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If chitosan is used for parenteral administration, then it provides biocompatibility and safety, but it activates immune cells and causes inflammatory responses
Solution Approach 1:
The patent modifies the chemical parameters of chitosan by introducing zwitterionic groups (carboxymethyl and sulfonate groups) to create chitosan derivatives with reduced positive charge density. This parameter change transforms the highly cationic chitosan into a zwitterionic polymer with near-neutral zeta potential, thereby reducing immune cell activation while maintaining biocompatibility
Solution Approach 2:
The patent creates composite structures by combining chitosan derivatives with dendrimers to form nanoparticle complexes. This composite material approach allows the chitosan derivative to provide biocompatibility and the dendrimer to provide targeting capabilities, while the overall structure reduces harmful immune activation compared to using pure chitosan
2Reliability
If chitosan is used at neutral pH, then it forms nanoparticles for drug delivery, but it has limited solubility
Solution Approach 1:
The patent changes the chemical composition parameters of chitosan by incorporating zwitterionic groups that provide both negative (carboxylate, sulfonate) and positive (ammonium) charges. This parameter modification enables the polymer to maintain solubility at neutral pH by balancing charges, while still allowing nanoparticle formation through controlled assembly of the zwitterionic derivatives
3Ease of operation
If PAMAM dendrimers are used for gene delivery, then they provide cationic charge for nucleic acid complexation, but they cause non-specific toxicity and reticuloendothelial system uptake
Solution Approach 1:
The patent uses chitosan derivatives as intermediary materials that mediate between the dendrimer core and the biological environment. The zwitterionic chitosan derivative coating on the dendrimer surface acts as a protective intermediary that reduces non-specific toxicity and reticuloendothelial system uptake while preserving the underlying cationic charge needed for gene delivery
Solution Approach 2:
The patent modifies the surface charge parameters of PAMAM dendrimers by coating them with zwitterionic chitosan derivatives. This parameter change reduces the net positive charge density at the surface, thereby reducing non-specific toxicity and immune recognition, while the dendrimer core retains sufficient cationic charge for nucleic acid complexation and gene delivery functionality
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The zwitterionic chitosan derivative demonstrates reduced immune activation, improved solubility, and effective delivery of dendrimers to cells, particularly in acidic tumor microenvironments, while also binding endotoxins and reducing inflammatory responses.
Implementation Method 1
chitosan is known to have a pKa of approximately 6.5. Therefore, chitosan is insoluble at a neutral pH but is positively charged and water-soluble at an acidic pH
Implementation Method 2
Development of a zwitterionic chitosan derivative with a tunable pH-dependent charge profile
Data Source
AI summary
The present disclosure provides a polymer comprising a derivative of chitosan, wherein the derivative is zwitterionic, as well as methods of using the polymer. In addition, the present disclosure provides a nanoparticle structure comprising a derivative of chitosan and a dendrimer, as well as methods of utilizing the nanoparticle structure.